Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Biocon LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532523NSE Symbol: BIOCONP/E(TTM):0
ISIN Demat:INE376G01013Div & Yield %:0.12EPS(TTM):0.09
Book Value(Rs):119.8499311Market Cap ( Cr.):49247.06Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 2242.602127.301992.901738.202028.401988.40
Excise Duty0.000.000.000.000.000.00
Net Sales2242.602127.301992.901738.202028.401988.40
Other Income 849.80207.503134.20187.20150.20366.00
Stock Adjustments 54.6099.10-3.20105.80-36.7031.40
Total Income3147.002433.905123.902031.202141.902385.80
EXPENDITURE :      
Raw Materials 1085.401033.80981.00914.00761.60859.10
Power & Fuel Cost192.00215.30279.20231.00186.00193.30
Employee Cost 501.30452.30433.80367.70390.20344.80
Other Manufacturing Expenses 163.80155.40127.10130.50147.00118.30
Selling and Administration Expenses 172.00135.00112.20106.70128.40208.40
Miscellaneous Expenses 6.90-28.1032.9033.0066.009.90
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure2121.401963.701966.201782.901679.201733.80
Operating Profit1025.60470.203157.70248.30462.70652.00
Interest 236.90198.8069.600.400.401.20
Gross Profit788.70271.403088.10247.90462.30650.80
Depreciation127.80121.10116.90108.20103.5098.00
Profit Before Tax660.90150.302971.20139.70358.80552.80
Tax30.6015.10132.7060.7073.50104.40
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax21.0015.90-9.90-7.104.807.50
Reported Net Profit609.30119.302848.4086.10280.50440.90
Extraordinary Items 564.4913.412861.732.923.00136.27
Adjusted Net Profit44.81105.89-13.3383.18277.50304.63
Adjst. below Net Profit -1.3030.7029.40-59.4030.4022.60
P & L Balance brought forward9920.509950.607132.807106.106795.206391.80
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 60.00180.1060.000.000.0060.10
P & L Balance carried down10468.509920.509950.607132.807106.106795.20
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %10.0010.0030.0010.000.000.00
Earnings Per Share-Unit Curr5.070.9923.720.722.343.67
Earnings Per Share(Adj)-Unit Curr5.070.9923.720.722.343.67
Book Value-Unit Curr95.9890.8890.9167.4065.8862.80